Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Pacer Advisors Inc.

Pacer Advisors Inc. trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.4% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 44,414 shares of the medical equipment provider’s stock after selling 1,563 shares during the period. Pacer Advisors Inc.’s holdings in Intuitive Surgical were worth $21,819,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Baillie Gifford & Co. grew its position in Intuitive Surgical by 0.6% during the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock worth $1,890,676,000 after purchasing an additional 24,183 shares in the last quarter. American Century Companies Inc. boosted its stake in shares of Intuitive Surgical by 3.0% during the 2nd quarter. American Century Companies Inc. now owns 2,398,193 shares of the medical equipment provider’s stock valued at $1,066,837,000 after buying an additional 70,556 shares during the period. Clearbridge Investments LLC boosted its stake in shares of Intuitive Surgical by 1.6% during the 2nd quarter. Clearbridge Investments LLC now owns 1,981,297 shares of the medical equipment provider’s stock valued at $881,380,000 after buying an additional 30,449 shares during the period. Assenagon Asset Management S.A. boosted its stake in shares of Intuitive Surgical by 15.4% during the 2nd quarter. Assenagon Asset Management S.A. now owns 1,483,406 shares of the medical equipment provider’s stock valued at $659,893,000 after buying an additional 197,841 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. boosted its stake in shares of Intuitive Surgical by 3.5% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,450,638 shares of the medical equipment provider’s stock valued at $712,655,000 after buying an additional 48,658 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts have issued reports on ISRG shares. Raymond James lifted their target price on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research note on Monday, October 14th. Evercore ISI reaffirmed a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research note on Friday, October 18th. Citigroup lifted their price objective on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Finally, Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $524.61.

Insider Transactions at Intuitive Surgical

In other news, SVP Mark Brosius sold 2,128 shares of the business’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the transaction, the senior vice president now owns 273 shares in the company, valued at approximately $140,595. The trade was a 88.63 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Amy L. Ladd sold 450 shares of the business’s stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $490.28, for a total transaction of $220,626.00. Following the transaction, the director now owns 821 shares in the company, valued at approximately $402,519.88. The trade was a 35.41 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 50,935 shares of company stock worth $26,305,169. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $547.87 on Friday. The firm has a market cap of $195.14 billion, a price-to-earnings ratio of 88.08, a P/E/G ratio of 5.30 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $304.50 and a fifty-two week high of $552.00. The firm has a fifty day moving average price of $504.73 and a two-hundred day moving average price of $463.02.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.